UPDATE: Aegis Capital Downgrades Galectin Therapeutics By: Benzinga via Benzinga August 01, 2014 at 12:26 PM EDT In a note released Friday morning, Aegis Capital analyst Raghuram Selvaraju downgraded shares of Galectin Therapeutics (NASDAQ: GALT) ... Read More >> Related Stocks: Galectin Therapeutic